Ceragon Networks Balances Cash Strength With Profit Squeeze
Ceragon Networks Ltd. ((CRNT)) has held its Q4 earnings call. Read on for the main highlights of the call.
President's Day Sale - 70% Off
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Ceragon Networks’ latest earnings call painted a cautiously constructive picture, balancing solid cash generation and a stronger balance sheet against steep revenue and profit declines. Management struck a tone of resolve, stressing disciplined execution and cost mitigation while reaffirming its longer-term growth and margin ambitions for 2026 despite near‑term headwinds.
Q4 Results Land on Target but Reflect Softer Demand
Ceragon delivered Q4 2025 revenue of $82.3 million, squarely within its prior guidance range and confirming earlier indications to the market. Non‑GAAP EPS came in at $0.02, matching the preliminary update shared in January and underscoring that the quarter, while weaker year over year, was at least predictable.
Full-Year 2025 Sees Double-Digit Revenue and Earnings Declines
For full‑year 2025, revenue fell 14.1% to $338.7 million, highlighting a meaningful reset in demand versus the prior year. Non‑GAAP EPS slid to $0.09, in line with previously communicated results but marking a sharp step down in profitability that investors will watch closely.
Cash Position and Liquidity Strengthen Despite Revenue Pressure
The company exited 2025 with cash and equivalents of $38.4 million, up about 8.8% year over year, and a net cash position of $19.4 million versus $10.1 million in 2024. Short‑term loans dropped from $25.2 million to $19.0 million, improving leverage and giving Ceragon more flexibility to navigate volatility.
Free Cash Flow Turns Positive as Operations Generate Cash
Ceragon posted more than $7 million of positive free cash flow in Q4, reflecting tighter working capital management. Net cash flow from operations and investing reached $7.3 million in the quarter and $15.1 million for 2025 when excluding acquisition costs, suggesting earnings quality was stronger than headline profit metrics imply.
Receivables and Collections Improve, Though DSO Still High
Trade receivables dropped to $99.7 million from $149.6 million, roughly a 33% reduction year over year that management tied to focused collection efforts, particularly in India. Days sales outstanding stood at 107 days, signaling progress but also that the company still faces an elongated cash conversion cycle.
Regional Performance Led by North America and India
Q4 revenue was driven by North America at $32.3 million and India at $24.7 million, confirming these markets as key pillars of the business. Ceragon also secured a multimillion‑dollar private network order in Asia‑Pacific and highlighted solid execution in North America alongside early booking momentum in India.
Product Roadmap Underpins Demand Visibility into 2026
Management outlined plans to launch four new products in 2026, with some expected to begin contributing revenue in their first year. Strong inbound interest ahead of industry events bolstered confidence that these offerings are aligned with customer needs and could support a demand recovery.
2026 Guidance Reaffirmed with Modest Margin Expansion
Ceragon reiterated its 2026 revenue outlook of $355 million to $385 million, implying mid‑single‑digit to low‑double‑digit growth from 2025 at the midpoint. The company expects roughly a one‑point improvement in non‑GAAP gross margin and targets non‑GAAP operating margins in the 6.5% to 7.5% range, signaling an intent to rebuild profitability.
Sharp Year-Over-Year Revenue Contraction in Q4
Despite meeting guidance, Q4 revenue declined 23% from $106.9 million a year earlier, reflecting softer demand in several regions and the timing of large orders. The significant top‑line drop underscores the cyclical and project‑driven nature of Ceragon’s business and the sensitivity of results to customer deployment schedules.
Profitability Under Strain with Net Income Down Dramatically
Non‑GAAP net income for Q4 fell to $1.4 million from $7.7 million, an approximately 81.8% decline that illustrates how operating leverage has turned against the company. For the full year, non‑GAAP net income sank to $8.2 million from $36.4 million, down about 77.5%, as weaker revenue and higher expense ratios compressed margins.
Operating Margins Compress as Scale Benefits Reverse
Non‑GAAP operating margin dropped to 5.3% for 2025 from 12.4% in 2024, a decline of roughly 7.1 percentage points that reflects lost scale and mix pressures. In Q4, operating margin fell to 4.2% from 11.4% a year earlier, underscoring how quickly profitability has eroded in the current demand environment.
Expense Ratios Rise Even as R&D Dollars Decline
Sales and marketing expenses increased to $11.4 million in Q4 and climbed to 13.8% of revenue versus 9.9% in the prior year, while general and administrative costs rose to 7.0% of revenue from 4.8%. Research and development spending declined in absolute terms but rose to 9.3% of revenue from 8.2%, showing Ceragon is maintaining product investment despite revenue pressure.
Inventory and Working Capital Metrics Still a Watch Item
Inventory edged up to $61.6 million from $59.7 million, indicating that stock levels remain elevated relative to current demand. With DSO still at 107 days, management acknowledged ongoing working capital risks, even as receivable balances have improved materially.
Component Cost Inflation Adds Near-Term Margin Risk
Ceragon highlighted a recent spike in memory component prices that could weigh on gross margins in the near term. Management is pursuing mitigation strategies such as multi‑sourcing and product changes, but cautioned that cost volatility introduces another layer of uncertainty around profitability.
Customer Concentration Heightens Revenue Volatility
Two customers represented more than 10% of revenue in Q4, reinforcing the company’s exposure to a small number of large accounts. This concentration could magnify swings in quarterly performance if major projects are delayed or if spending patterns shift suddenly.
Outlook Anchored by 2026 Growth Ambitions
The company’s 2026 guidance assumes continued conversion of its North American backlog, a baseline $100 million annualized contribution from India and incremental demand from two existing large customers. Management also factors in potential wins in new bids, contributions from four new products and some sensitivity to currency moves, supporting a view of moderate growth and margin repair.
Ceragon’s earnings call offered a nuanced story for investors, with robust cash generation and an improving balance sheet offsetting a difficult revenue and margin picture. The reaffirmed 2026 outlook, expanding product lineup and key regional pipelines provide a path to recovery, but execution on costs, working capital and customer diversification will be critical to rebuilding shareholder confidence.
